{
    "clinical_study": {
        "@rank": "166739", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die.\n\n      PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients who\n      have locally advanced, metastatic, or recurrent cancer of the vulva."
        }, 
        "brief_title": "Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva", 
        "condition": "Vulvar Cancer", 
        "condition_browse": {
            "mesh_term": "Vulvar Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the therapeutic activity of paclitaxel in patients with locally advanced,\n           metastatic, or recurrent squamous cell carcinoma of the vulva.\n\n        -  Determine the objective response rate and duration of response in these patients\n           treated with this drug.\n\n        -  Determine the acute side effects of this drug in these patients.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients receive paclitaxel IV over 3 hours on day 1. Treatment repeats every 21 days for a\n      maximum of 10 courses in the absence of disease progression or unacceptable toxicity.\n\n      Patients are followed every 9 weeks.\n\n      PROJECTED ACCRUAL: A total of 16-29 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically confirmed squamous cell carcinoma of the vulva\n\n               -  Not suitable for radiotherapy or surgery as first-line treatment\n\n          -  Measurable or evaluable disease\n\n               -  At least 1 bidimensionally measurable target lesion\n\n               -  Measurable metastatic disease outside previously irradiated areas OR\n\n               -  Local recurrence within a previously treated area OR\n\n               -  Local lesions showing progression while on treatment\n\n          -  No brain metastasis\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  18 and over\n\n        Performance status:\n\n          -  WHO 0-2\n\n          -  ECOG 0-2\n\n        Life expectancy:\n\n          -  At least 3 months\n\n        Hematopoietic:\n\n          -  Not specified\n\n        Hepatic:\n\n          -  Bilirubin no greater than 1.5 mg/dL\n\n          -  AST/ALT less than 2 times upper limit of normal\n\n        Renal:\n\n          -  Creatinine clearance greater than 60 mL/min\n\n        Cardiovascular:\n\n          -  No prior or concurrent cardiac disease (i.e., uncontrolled high blood pressure,\n             unstable angina, congestive heart failure, myocardial infarction within the past\n             year, cardiac ventricular arrhythmia requiring medication, or 2nd or 3rd degree heart\n             block)\n\n        Other:\n\n          -  No peripheral neuropathy greater than grade 1\n\n          -  No serious active infection\n\n          -  No prior allergic reaction to drugs containing Cremophor EL\n\n          -  No other serious medical, psychological, familial, or social condition that would\n             preclude study\n\n          -  Not pregnant or nursing\n\n          -  Fertile patients must use effective contraception\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  No prior chemotherapy except as concurrent therapy with radiotherapy\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  See Disease Characteristics\n\n          -  See Chemotherapy\n\n          -  No concurrent radiotherapy\n\n        Surgery:\n\n          -  Not specified"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "31", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 10, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00014599", 
            "org_study_id": "EORTC-55985", 
            "secondary_id": "EORTC-55985"
        }, 
        "intervention": {
            "intervention_name": "paclitaxel", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Paclitaxel"
        }, 
        "keyword": [
            "stage III vulvar cancer", 
            "stage IV vulvar cancer", 
            "recurrent vulvar cancer", 
            "squamous cell carcinoma of the vulva"
        ], 
        "lastchanged_date": "September 20, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-55985"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "B-2650"
                    }, 
                    "name": "Universitair Ziekenhuis Antwerpen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76038"
                    }, 
                    "name": "Centre Henri Becquerel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20141"
                    }, 
                    "name": "European Institute of Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "zip": "10128"
                    }, 
                    "name": "Ospedale Mauriziano Umberto I"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varese", 
                        "country": "Italy", 
                        "zip": "21100"
                    }, 
                    "name": "Ospedale di Circolo e Fondazione Macchi"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Voghera", 
                        "country": "Italy", 
                        "zip": "27058"
                    }, 
                    "name": "Ospedale Civile"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1105 AZ"
                    }, 
                    "name": "Academisch Medisch Centrum"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "NL-6500 HB"
                    }, 
                    "name": "University Medical Center Nijmegen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3508 GA"
                    }, 
                    "name": "Academisch Ziekenhuis Utrecht"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Coimbra", 
                        "country": "Portugal", 
                        "zip": "3001-301"
                    }, 
                    "name": "Hospitais da Universidade de Coimbra (HUC)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Merseyside", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "CH63 4JY"
                    }, 
                    "name": "Clatterbridge Centre for Oncology NHS Trust"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Romford", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "RM7 OBE"
                    }, 
                    "name": "Oldchurch Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G11 6NT"
                    }, 
                    "name": "Western Infirmary"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "France", 
                "Italy", 
                "Netherlands", 
                "Portugal", 
                "United Kingdom"
            ]
        }, 
        "official_title": "Phase II Clinical Trial On Taxol As Single Agent In Locally Advanced And/Or Metastatic Or Recurrent Vulva Cancer Not Amenable For Surgery And/Or Radiotherapy", 
        "overall_official": {
            "affiliation": "UMC Utrecht", 
            "last_name": "Els Witteveen, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2005", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00014599"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "19487487", 
            "citation": "Witteveen PO, van der Velden J, Vergote I, Guerra C, Scarabeli C, Coens C, Demonty G, Reed N. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group). Ann Oncol. 2009 Jun 1; [Epub ahead of print]"
        }, 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2001", 
        "study_design": "Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }, 
    "geocoordinates": {
        "Academisch Medisch Centrum": "52.37 4.895", 
        "Academisch Ziekenhuis Utrecht": "52.09 5.11", 
        "Centre Henri Becquerel": "49.443 1.1", 
        "Clatterbridge Centre for Oncology NHS Trust": "53.398 -2.944", 
        "European Institute of Oncology": "45.464 9.188", 
        "Hospitais da Universidade de Coimbra (HUC)": "40.211 -8.429", 
        "Oldchurch Hospital": "51.577 0.178", 
        "Ospedale Civile": "44.992 9.01", 
        "Ospedale Mauriziano Umberto I": "45.071 7.684", 
        "Ospedale di Circolo e Fondazione Macchi": "45.818 8.826", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Universitair Ziekenhuis Antwerpen": "51.153 4.438", 
        "University Medical Center Nijmegen": "51.843 5.855", 
        "Western Infirmary": "55.864 -4.252"
    }
}